Bioasis Technologies (FRA:107) EV-to-Revenue : 10.11 (As of Jun. 19, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Bioasis Technologies EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Bioasis Technologies's enterprise value is €2.03 Mil. Bioasis Technologies's Revenue for the trailing twelve months (TTM) ended in Nov. 2022 was €0.20 Mil. Therefore, Bioasis Technologies's EV-to-Revenue for today is 10.11.

The historical rank and industry rank for Bioasis Technologies's EV-to-Revenue or its related term are showing as below:

FRA:107's EV-to-Revenue is not ranked ^*
in the Biotechnology industry.
Industry Median: 7.57
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-19), Bioasis Technologies's stock price is €0.008. Bioasis Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Nov. 2022 was €0.00. Therefore, Bioasis Technologies's PS Ratio for today is 4.00.

Bioasis Technologies EV-to-Revenue Historical Data

The historical data trend for Bioasis Technologies's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioasis Technologies EV-to-Revenue Chart

Bioasis Technologies Annual Data

Trend

Feb13

Feb14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

EV-to-Revenue

Get a 7-Day Free Trial

54.10

16.76

24.83

5.73

512.98

Bioasis Technologies Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
EV-to-Revenue	Get a 7-Day Free Trial															554.51	512.98	402.70	89.51	56.36

Competitive Comparison of Bioasis Technologies's EV-to-Revenue

For the Biotechnology subindustry, Bioasis Technologies's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioasis Technologies's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioasis Technologies's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bioasis Technologies's EV-to-Revenue falls into.

Bioasis Technologies EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Bioasis Technologies's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	2.032	/	0.201
	=	10.11

Bioasis Technologies's current Enterprise Value is €2.03 Mil.
Bioasis Technologies's Revenue for the trailing twelve months (TTM) ended in Nov. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.20 Mil.

Bioasis Technologies (FRA:107) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Bioasis Technologies's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.008	/	0.002
	=	4.00

Bioasis Technologies's share price for today is €0.008.
Bioasis Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Nov. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.

Bioasis Technologies EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bioasis Technologies's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioasis Technologies (FRA:107) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioasis Technologies Inc (FRA:107) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

157 Church Street, 19th Floor, New Haven, CT, USA, 06510

Website

https://www.bioasis.us

Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company has worked on a blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The company's in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

Bioasis Technologies (FRA:107) Headlines

No Headlines